Drug Launch
The latest news about Drug Launch: headlines, AI summaries and the full story from every source.
- FDA Approves Pimjetmi for Tenosynovial Giant Cell Tumor
- Vertex Pharmaceuticals Reports 12% Revenue Growth Driven by Alyftrek Transition
- Argenx Projects 2026 Operating Expenses at $4 Billion Amid U.S. Expansion Plans
- Insmed's New Drug Launch Transforms Financial Performance
- Roivant Sciences Reports Profitability, Shares Rise 15%
- Sarepta Therapeutics' Q1 Performance Surpasses Expectations Amid Elevidys Challenges
- Raymond James Initiates Coverage on Insmed with Outperform Rating
- Eli Lilly Reports Strong Q1 2026 Earnings and Announces New Obesity Drug Approval
- Alnylam Pharmaceuticals Reports Strong First-Quarter Sales for Amvuttra